CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
======================================================================================================================

* Regina Jitschin
* Domenica Saul
* Martina Braun
* Sehmus Tohumeken
* Simon Völkl
* Roman Kischel
* Michael Lutteropp
* Cedric Dos Santos
* Andreas Mackensen
* Dimitrios Mougiakakos